Sequencing and Positioning Antipsychotic Formulations in Schizophrenia Care
Dr. Hara Oyedeji discusses the strategic sequencing of antipsychotic medications for schizophrenia, emphasizing the importance of early intervention and patient-centered formulation selection. She highlights the benefits of long-acting injectables for maintaining long-term stability.
Why it matters
Optimizing treatment pathways for schizophrenia is essential for improving patient adherence and long-term cognitive outcomes.
In this episode, "Sequencing and Positioning Antipsychotic Formulations in Schizophrenia Care," the expert psychiatric mental health nurse practitioner Dr. Hara Oyedeji explores the nuanced decision-making process behind sequencing and positioning oral, long-acting injectable, and transdermal antipsychotic formulations across the schizophrenia treatment journey.
Professional medical advice and clinical best practices reporting.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in